| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing glatiramer (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
|
| Product containing sirolimus (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sirolimus 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
|
| sirolimus 1 mg oral opløsning i pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
|
| sirolimus 2 mg oral opløsning i brev |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
|
| Sirolimus 1mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
|
| Sirolimus 1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
|
| Glatiramer acetate 20mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
|
| Glatiramer acetate 20 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
|
| glatirameracetat 20 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
|
| Sirolimus 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
|
| Sirolimus 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
|
| sirolimus 140 µg/ml lægemiddeleluerende stent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Blood sirolimus measurement (procedure) |
Component |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
2 |
| Measurement of sirolimus (procedure) |
Component |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Sirolimus therapy (procedure) |
Direct substance |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
2 |
| Sirolimus 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Sirolimus 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Sirolimus 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Sirolimus 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Product containing sirolimus in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Sirolimus 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Sirolimus 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sirolimus 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely sirolimus 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Sirolimus only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Product containing only sirolimus in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Sirolimus 140 microgram/cm2 drug eluting stent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
| Blood sirolimus measurement (procedure) |
Component |
True |
Sirolimus (substance) |
Inferred relationship |
Some |
1 |
FHIR